Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
[26] [27] Retatrutide could potentially be considered for this route given its novel mechanism, though no ILAP designation has been announced and eligibility would need to be assessed formally by the MHRA
It isnt the same as VIP and shouldnt be viewed as a direct Shoemaker Protocol replacement, but it may help calm inflammatory input from the gut in some patients
Health Canada authorization does not automatically trigger formulary listing
Unfortunately, for some people, this can result in super negative side effects like nausea, vomiting, and diarrhea - one study reported that 50% of patients taking GLP-1 agonists experienced nausea while taking them
Dosage & Administration ['Adults: 1 effervescent tablet in 200 ml water once daily', 'Drink immediately after dissolving', 'Take on an empty stomach for best absorption', 'Continue for 812 weeks'] Side Effects ['Generally well tolerated', 'Mild GI upset', 'Allergic reaction (rare)', 'Sulfurous taste in some patients'] Contraindications & Precautions ['Hypersensitivity to glutathione or vitamin C', 'G6PD deficiency (caution)', 'Active peptic ulcer'] Storage Store below 25C, keep bottle tightly closed
